ConELA Report Shows Only Six Spanish Regions Fully Implement ALS Aid Law

A landmark Spanish law meant to help ALS patients get immediate care is failing most of them. Only six of Spain's 17 autonomous communities are actually delivering the financial aid the law requires, according to ConELA, the national confederation of ALS entities.
ConELA presented its first implementation audit on June 18 in Madrid. The report paints a stark picture: roughly 4,000 ALS patients in Spain, 900 new diagnoses every year, and an estimated 1,000 people who died between the law's passage in 2024 and its real-world rollout in late 2025 — without ever receiving a single euro in aid.
Spain's parliament passed Ley ELA in October 2024 with unanimous support — a rare political feat. The law created two key rights. First, automatic Grade III dependency status, meaning ALS patients skip the usual 6-to-12-month wait for aid. Second, recognition of 24-hour continuous care, because advanced patients cannot be left alone for even a minute.
The government followed up in October 2025 with a decree providing the first €500 million in funding. But Spain's social services are managed by its 17 regions — not Madrid. The central government sets the rights. The regions deliver them. That gap is where the law has stalled, according to El Periódico de Aragón.
Extremadura leads the way. It passed its own regional decree in March 2026 and now offers monthly aid ranging from €3,200 to €9,859 per patient — the highest in the country. Catalonia has processed 95 applications and approved 85, with money already flowing. Valencia began paying families in late March 2026. These regions cut bureaucratic wait times from six months down to two.
Most regions have not moved that fast. Patients in Andalusia and Castilla-La Mancha still face delays. ConELA president José Jiménez Aroca put it plainly: "A law does not end when it is published. It truly begins when it changes people's lives." For thousands of patients, that change has not come.
A second battle is brewing over copayments. Madrid, Aragon, and Cantabria are reducing patient aid by up to 40% based on a family's income. Regions like Asturias and La Rioja cover 100% of costs. Advocates call the copayment approach a "betrayal of the law's spirit." ConELA is preparing court challenges, arguing these reductions gut the national law's core guarantee.
Regional governments on the other side say the national law was an unfunded mandate. Without larger transfers from Madrid, they argue means-testing is the only way to keep their social care systems solvent. The result is what patient groups are calling "territorial discrimination" — your care depends on your postal code.
The cost of ALS care without public help runs about €170,000 per year. That figure is destroying family finances in regions that lag behind. Reports are emerging of "ALS tourism" — families considering moving to Extremadura or Catalonia simply to access the aid they are legally entitled to receive anywhere in Spain.
The Spanish Society of Neurology warns the crisis will deepen. ALS cases in Europe are projected to rise 40% over the next 25 years. Better care means patients live longer — which means higher system costs. ConELA's message is simple: the law exists, the money exists, the need is urgent. "The benefits must arrive quickly," the group said in its report.
Publishers
6
Articles
0
Reach
6